INTRODUCTION: Dihydroquercetin, as a natural polyphenol with a wide spectrum of pharmacological activity, can inhibit free radical formation process which plays a significant role in the pathogenesis of diabetes mellitus. However, currently, flavonoid antioxidants, in particular, dihydroquercetin are not included in the recommendations for the treatment of diabetes mellitus, which may be due to its low biological availability and some other factors. Earlier, a spheroidal form of dihydroquercetin (DHQsph) was obtained from the pharmaceutical substance dihydroquercetin by spray drying, characterized by better solubility, prolonged liberation and a higher safety profile. AIM: Identification of the effect of (DHQsph) on the antioxidant capacity of blood plasma of rats with streptozotocin-induced diabetes mellitus. MATERIALS AND METHODS: The study used plasma of adult male Wistar rats divided into three groups. The antioxidant capacity of intact plasma samples and of a model mixture of DHQsph solution with blood plasma from healthy rats was evaluated using modified ABTS/PP-method. RESULTS: The antioxidant capacity of blood plasma of rats with streptozotocin-induced diabetes mellitus decreased by 15% relative to the healthy group, however, no differences were found between groups with streptozotocin-induced diabetes treated and not treated with DHQsph. The model mixture of plasma with added DHQsph was shown to have 32% lower antioxidant capacity than the theoretically calculated additive sum. CONCLUSION: Antioxidant capacity of plasma of rats with diabetes was significantly lower in comparison with that of the healthy group. The effect of masking of antioxidant capacity of dihydroquercetin with blood plasma of rats was demonstrated on the model mixture of plasma with the added spheroidal form of dihydroquercetin.
Read full abstract